Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Neuroendocrine carcinoma
ADR ID BADD_A08300
ADR Hierarchy
05      Endocrine disorders
05.08      Neoplastic and ectopic endocrinopathies
05.08.01      Endocrine neoplasms NEC
05.08.01.011      Neuroendocrine carcinoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.24      Endocrine neoplasms malignant and unspecified
16.24.01      Endocrine neoplasms malignant and unspecified NEC
16.24.01.007      Neuroendocrine carcinoma
Description A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992) [MeSH]
MedDRA Code 10057270
MeSH ID D018278
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Neuroendocrine carcinoma | Carcinoma, Neuroendocrine | Carcinomas, Neuroendocrine | Neuroendocrine Carcinoma | Neuroendocrine Carcinomas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00014Abiraterone0.000334%
BADD_D00047Afatinib0.000112%
BADD_D00195Azathioprine0.000627%
BADD_D00271Bicalutamide0.001406%
BADD_D00474Cisplatin0.000168%
BADD_D01253Lenalidomide0.000362%
BADD_D01831Prednisolone0.000035%
BADD_D01835Pregabalin0.000052%
BADD_D01913Ranitidine0.000038%
BADD_D02100Sunitinib0.000627%
BADD_D02150Temozolomide--
BADD_D02236Tofacitinib0.000241%
BADD_D02412Octreotide--
BADD_D02464Fingolimod0.000362%
The 1th Page    1    Total 1 Pages